We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+10.73%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$188M
AUM Growth
+$30.7M
Cap. Flow
+$18.4M
Cap. Flow %
9.8%
Top 10 Hldgs %
6.1%
Holding
495
New
69
Increased
189
Reduced
162
Closed
73

Top Sells

Rank Stock Value
1
BURL icon
Burlington
BURL
+$962K
2
PLD icon
Prologis
PLD
+$773K
3
BKNG icon
Booking.com
BKNG
+$734K
4
ETN icon
Eaton
ETN
+$720K
5
TEL icon
TE Connectivity
TEL
+$708K

Sector Composition

Rank Sector Weight
1 Healthcare 21.52%
2 Financials 20.16%
3 Technology 16.46%
4 Industrials 8.76%
5 Energy 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BCRX icon
226
BioCryst Pharmaceuticals
BCRX
$2.42B
$301K 0.16%
59,257
+8,526
+17% +$47.9K
IRWD icon
227
Ironwood Pharmaceuticals
IRWD
$586M
$290K 0.15%
33,277
+4,788
+17% +$58.1K
MIRM icon
228
Mirum Pharmaceuticals
MIRM
$6.56B
$277K 0.15%
11,015
+1,585
+17% +$43.6K
RNAM
229
DELISTED
Avidity Biosciences
RNAM
$275K 0.15%
10,789
-740
-6% -$11.6K
VERA icon
230
Vera Therapeutics
VERA
$2.33B
$254K 0.13%
5,886
-403
-6% -$14.4K
ACAD icon
231
Acadia Pharmaceuticals
ACAD
$4.51B
$251K 0.13%
13,579
+1,954
+17% +$48.4K
APGE icon
232
Apogee Therapeutics
APGE
$10.1B
$248K 0.13%
3,727
-257
-6% -$11.2K
WES icon
233
Western Midstream Partners
WES
$19.4B
$228K 0.12%
+6,421
New +$199K
SCCO icon
234
Southern Copper
SCCO
$138B
$228K 0.12%
2,310
-572
-20% -$45.7K
SYRE icon
235
Spyre Therapeutics
SYRE
$8.5B
$221K 0.12%
5,838
-401
-6% -$11.6K
IMO icon
236
Imperial Oil
IMO
$62.3B
$221K 0.12%
+3,190
New +$195K
OUT icon
237
Outfront Media
OUT
$5.75B
$217K 0.12%
+13,158
New +$185K
SANA icon
238
Sana Biotechnology
SANA
$882M
$217K 0.12%
21,714
-1,489
-6% -$11.2K
VNOM icon
239
Viper Energy
VNOM
$8.43B
$217K 0.12%
5,630
-1,614
-22% -$54.6K
OVV icon
240
Ovintiv
OVV
$17B
$214K 0.11%
+4,118
New +$188K
VRN
241
DELISTED
Veren
VRN
$214K 0.11%
26,090
+498
+2% +$3.49K
CNQ icon
242
Canadian Natural Resources
CNQ
$96.9B
$213K 0.11%
+5,588
New +$187K
AUPH icon
243
Aurinia Pharmaceuticals
AUPH
$1.95B
$211K 0.11%
42,195
+6,071
+17% +$41.2K
DYN icon
244
Dyne Therapeutics
DYN
$4.68B
$208K 0.11%
7,326
-507
-6% -$11.5K
PAA icon
245
Plains All American Pipeline
PAA
$17.6B
$208K 0.11%
+11,832
New +$191K
HESM icon
246
Hess Midstream
HESM
$5.19B
$206K 0.11%
5,712
-1,115
-16% -$37.7K
BRY
247
DELISTED
Berry Corp
BRY
$206K 0.11%
+25,600
New +$179K
PAGP icon
248
Plains GP Holdings
PAGP
$5.28B
$205K 0.11%
+11,260
New +$190K
TS icon
249
Tenaris
TS
$28.2B
$202K 0.11%
+5,153
New +$178K
ZLAB icon
250
Zai Lab
ZLAB
$2.07B
$202K 0.11%
12,613
+1,815
+17% +$38.2K

Similar funds

Virtus ETF Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, Virtus ETF Advisers held 495 positions worth $188M, up 19% from $158M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $18.4M of net new capital in Q1 2024, opening 69 new positions and adding to 189 existing holdings. Its largest new stake was Host Hotels & Resorts: 47,997 shares worth $993K.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was ConocoPhillips, an estimated $569K trimmed.

  • Virtus ETF Advisers's largest Q1 2024 buy was Host Hotels & Resorts: 47,997 shares worth $993K.
  • Virtus ETF Advisers added most to BlackRock TCP Capital in Q1 2024, an estimated $1.06M increase.
  • Virtus ETF Advisers's biggest Q1 2024 reduction was ConocoPhillips, cutting an estimated $569K.
  • Virtus ETF Advisers fully exited Burlington in Q1 2024, selling an estimated $962K.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $188M portfolio in Q1 2024.
  • Virtus ETF Advisers opened 69 new positions and closed 73 in Q1 2024.
  • Virtus ETF Advisers's portfolio value rose 19% quarter-over-quarter to $188M.

Based on Virtus ETF Advisers's 13F filing for Q1 2024, filed 15 May 2024.